13 November 2023
Latham & Watkins Advises Inari Medical in Acquisition of LimFlow
Advising firms
Deal team
36 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julie Scallen Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Pierre-Louis Cléro Lead | Latham & Watkins LLP | Partner | corporate | Paris |
| Andrew Moosmann | Latham & Watkins LLP | Counsel | corporate | Not stated |
| Taylor Ashton | Latham & Watkins LLP | Associate | corporate | Not stated |
| Kennedy Holmes | Latham & Watkins LLP | Associate | corporate | Not stated |
| Amy Lutfi | Latham & Watkins LLP | Associate | corporate | Not stated |
| Christos Ierna | Latham & Watkins LLP | Associate | corporate | Not stated |
| Juliette Gilioli | Latham & Watkins LLP | Associate | corporate | Not stated |
| Shayne Kennedy | Latham & Watkins LLP | Partner | public company matters | Orange County |
| Ross McAloon | Latham & Watkins LLP | Partner | public company matters | Orange County |
| Eric Hanzich | Latham & Watkins LLP | Associate | public company matters | Not stated |
| AJ Blair | Latham & Watkins LLP | Associate | public company matters | Not stated |
| Charles Sanders | Latham & Watkins LLP | Partner | IP and data privacy | Boston |
| Sarah Gagan | Latham & Watkins LLP | Partner | IP and data privacy | Boston |
| Debbie Hinck | Latham & Watkins LLP | Associate | IP and data privacy | Not stated |
| Drew Roberts | Latham & Watkins LLP | Associate | IP and data privacy | Not stated |
| Zachary Shufro | Latham & Watkins LLP | Associate | IP and data privacy | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Kathryn Culver | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Leia Gu | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | EU healthcare regulatory | Paris/Brussels |
| Jeanne Fabre | Latham & Watkins LLP | Associate | EU healthcare regulatory | Not stated |
| Alexandra Lauré | Latham & Watkins LLP | Associate | EU healthcare regulatory | Not stated |
| Héctor Armengod | Latham & Watkins LLP | Partner | EU antitrust | Brussels |
| Markus Welzenbach | Latham & Watkins LLP | Associate | EU antitrust | Not stated |
| Victoria Pfaff | Latham & Watkins LLP | Associate | EU antitrust | Not stated |
| Patrick English | Latham & Watkins LLP | Counsel | US antitrust | Washington, D.C. |
| Kimon Kimball Triantafyllou | Latham & Watkins LLP | Associate | US antitrust | Not stated |
| Nicholas DeNovio | Latham & Watkins LLP | Partner | US tax | Washington, D.C. |
| Pierce Pandolph | Latham & Watkins LLP | Associate | US tax | Not stated |
| Emmanuel Kassim | Latham & Watkins LLP | Associate | US tax | Not stated |
| Olivia Rauch-Ravisé | Latham & Watkins LLP | Partner | French tax | Paris |
| Hugo Matricon | Latham & Watkins LLP | Associate | French tax | Not stated |
| Michelle Carpenter | Latham & Watkins LLP | Partner | US benefits | Los Angeles |
| Sara Schlau | Latham & Watkins LLP | Associate | US benefits | Not stated |
Stated terms
- Stated value
- USD 250m (US$250 million)
- What the figure measures
- Total transaction value
- Client
- Inari Medical, Inc.Buy-side
- Counterparties
- LimFlow, S.A. (Sell-side)